These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37154247)

  • 1. MRTF-A/SRF signaling suppresses invasion of oral squamous cell carcinoma.
    Yang D; Yang D; He Y; Liu J; Song Y; Zhou Y; Jiang L; Zeng X; Xu X; Xu H; Li J; Dan H
    Oral Dis; 2024 May; 30(4):1919-1934. PubMed ID: 37154247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
    PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
    Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
    Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4.
    Wei D; Wang W; Shen B; Zhou Y; Yang X; Lu G; Yang J; Shao Y
    Int J Mol Med; 2019 Jul; 44(1):185-195. PubMed ID: 31059001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway.
    Zhao Z; Chu W; Zheng Y; Wang C; Yang Y; Xu T; Yang X; Zhang W; Ding X; Li G; Zhang H; Zhou J; Ye J; Wu H; Song X; Wu Y
    Cell Commun Signal; 2021 Dec; 19(1):121. PubMed ID: 34922580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTA1 promotes the invasion and migration of oral squamous carcinoma by inducing epithelial-mesenchymal transition via the hedgehog signaling pathway.
    Song Q; Wang B; Liu M; Ren Z; Fu Y; Zhang P; Yang M
    Exp Cell Res; 2019 Sep; 382(1):111450. PubMed ID: 31152708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRELP inhibits the progression of oral squamous cell carcinoma via inactivation of the NF-κB pathway.
    Sun X; Chai L; Wang B; Zhou J
    Arch Oral Biol; 2024 Nov; 167():106068. PubMed ID: 39151326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-22 promotes the migration and invasion of oral squamous cell carcinoma cells.
    Komine-Aizawa S; Aizawa S; Takano C; Hayakawa S
    Immunol Med; 2020 Sep; 43(3):121-129. PubMed ID: 32546118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
    Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA MAGEA4-AS1 binding to p53 enhances MK2 signaling pathway and promotes the proliferation and metastasis of oral squamous cell carcinoma.
    Wei X; Li Z; Zheng H; Li X; Lin Y; Yang H; Shen Y
    Funct Integr Genomics; 2024 Sep; 24(5):158. PubMed ID: 39249547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p/PLOD1/Akt/mTOR pathway.
    Liu J; Zhang Y; Wu J; Liu X; Li L; Zhang J
    Cancer Genet; 2024 Jun; 284-285():48-57. PubMed ID: 38729078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
    Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
    J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Cheng CW; Hsiao JR; Fan CC; Lo YK; Tzen CY; Wu LW; Fang WY; Cheng AJ; Chen CH; Chang IS; Jiang SS; Chang JY; Lee AY
    Mol Carcinog; 2016 May; 55(5):499-513. PubMed ID: 25728212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.
    Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L
    Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
    Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
    J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.
    Zhang AM; Chi XH; Bo ZQ; Huang XF; Zhang J
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31439759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Casticin inhibits invasion and proliferation via downregulation of β-catenin and reversion of EMT in oral squamous cell carcinoma.
    Xie Y; Zhong L; Duan D; Li T
    J Oral Pathol Med; 2019 Nov; 48(10):897-905. PubMed ID: 31318467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of VHL expression contributes to epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Zhang S; Zhou X; Wang B; Zhang K; Liu S; Yue K; Zhang L; Wang X
    Oral Oncol; 2014 Sep; 50(9):809-17. PubMed ID: 24998140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities.
    Ling Z; Cheng B; Tao X
    Int J Cancer; 2021 Apr; 148(7):1548-1561. PubMed ID: 33091960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.